Concurrent Investment Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,378
Closed -$270K 940
2024
Q1
$270K Sell
9,378
-1,656
-15% -$47.6K 0.01% 697
2023
Q4
$362K Buy
+11,034
New +$362K 0.02% 584